Clinical Trial

Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)

Study acronym: EPO-LT
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a national multicenter, randomized clinical trial to evaluate the the efficacy and safety of DP administration in patients on the liver transplant waiting list to reduce intraoperative red blood cell concentrate transfusion.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-09; most recent amendment 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2025-12-11
Trial Details
NCT Number NCT07169643
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Conditions Liver Transplant; Complications
Enrollment 140 participants
Start Date 2025-11-25
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-18